Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Evaluation of a Comorbidity-Oriented Auditory-Cognitive Optimization Care Program (A-COP) for Individuals With Hearing Loss and Cognitive Impairment: A Longitudinal, Single-Blind, Two-Arm, Parallel-Group Randomized Controlled Trial

NCT07869745 is registered in ClinicalTrials.gov with Taipei Medical University as lead sponsor.

NCT NCT07869745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07869745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Evaluation of a Comorbidity-Oriented Auditory-Cognitive Optimization Care Program (A-COP) for Individuals With Hearing Loss and Cognitive Impairment: A Longitudinal, Single-Blind, Two-Arm, Parallel-Group Randomized Controlled Trial
Lead sponsor
Taipei Medical University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 28, 2027
Completion date
December 31, 2030
Enrollment
76 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, hearing loss